2026

Pathway for the development of ATR inhibitors in pediatric malignancies: an ACCELERATE multistakeholder analysis.
Gatz, Susanne A., Glade-Bender, Julia, Pearson, Andrew D.J., Ortiz, Michael V., Bernardi, Ronald, Chesler, Lou, Clifford, Steve, Cohen-Gogo, Sarah, De La Cuesta, Esther, de Rojas, Teresa, Durinck, Kaat, Federico, Sara, Fox, Elizabeth, George, Sally, Gounaris, Ioannis, Henssen, Anton George, Irwin, Meredith, Kool, Marcel, Lau, Alan, Nysom, Karsten, Pappo, Alberto, Pennock, Gregory K., Pfister, Stefan M., Scobie, Nicole, Slotkin, Emily K., Smith, Malcolm, Speleman, Frank, Stewart, Elizabeth A., Weigel, Brenda J. and Vassal, Gilles
JCO Precision Oncology 10 : e2500642. January 2026

2022

Genomic evolution and personalized therapy of an infantile fibrosarcoma harboring an NTRK oncogenic fusion.
Thorwarth, A., Haase, K., Röefzaad, C., Pajtler, K.W., Schramm, K., Hauptmann, K., Behnke, A., Vokuhl, C., Elgeti, T., Gratopp, A., Schulte, J.H., Scheer, M., Hernáiz Driever, P., Nysom, K., Eggert, A., Henssen, A.G. and Deubzer, H.E.
JCO Precision Oncology 6 : e2100283. 25 May 2022